low serum contactin-1 predicts disability progression in ms
Published 3 years ago • 44 plays • Length 4:27Download video MP4
Download video MP3
Similar videos
-
4:59
serum biomarkers of brain atrophy in ms
-
1:38
blood serum proteome correlates of ms disease progression: a 5-year longitudinal study
-
2:13
differential diagnosis of ms patients using serum proteomics: disease state & ms subtype
-
1:34
serum neurofilament levels are associated with health outcomes and resource use in ms
-
4:48
serum neurofilament light chain levels as a biomarker in ms
-
1:45
ms disease stage modulates the relationship between serum neurofilament light and age
-
3:14
sgfap as a biomarker in nmosd
-
1:18
pharmacological inhibition of c1q in multiple sclerosis
-
5:01
shifting toward precision care in ms using disease activity tests and serum biomarkers
-
4:10
the importance of early treatment in multiple sclerosis
-
3:01
vascular disease risk factors in multiple sclerosis patients
-
2:13
lipid-based therapies for ms
-
1:00
clinical trial for ms treatment shows promise in slowing disability progression.
-
3:06
what is minimal residual testing in multiple myeloma?
-
0:42
do you know multiple sclerosis more prevalent in certain areas #multiplesclerosis #ms #healthcare
-
0:15
a worse ms prognosis?
-
1:32
chromatic alterations in multiple sclerosis
-
0:34
skin medica "must have kit" - includes two essential serums!
-
2:04
early treatment for ms may reduce the risk of later disability